Cart
sales@molnova.com
Ferric maltol
CAS No. 33725-54-1
Ferric maltol( Iron(III) 2-methyl-4-oxo-4H-pyran-3-olate )
Catalog No. M26564 CAS No. 33725-54-1
Ferric maltol is a ferric, non-salt-based oral iron formulation demonstrating improved tolerance in patients with previous intolerance to other iron formulations.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 126 | In Stock |
|
| 2MG | 70 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 183 | In Stock |
|
| 25MG | 353 | In Stock |
|
| 50MG | 508 | In Stock |
|
| 100MG | 709 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFerric maltol
-
NoteResearch use only, not for human use.
-
Brief DescriptionFerric maltol is a ferric, non-salt-based oral iron formulation demonstrating improved tolerance in patients with previous intolerance to other iron formulations.
-
DescriptionFerric maltol is a ferric, non-salt-based oral iron formulation demonstrating improved tolerance in patients with previous intolerance to other iron formulations.(In Vitro):Ferric maltol increases transferrin saturation and levels of serum ferritin, serum iron, blood hemoglobin, and reticulocyte hemoglobin.(In Vivo):Iron that is not absorbed from Ferric maltol can remain in its chelated form at least throughout the small intestine, minimizing the risk of intestinal mucosal damage from free iron and potentially reducing local toxicity.
-
In VitroThe administration of Ferric maltol can increase transferrin saturation and levels of serum iron, serum ferritin, reticulocyte hemoglobin, and blood hemoglobin.
-
In VivoAnimal studies show that iron that is not absorbed from Ferric maltol can remain in its chelated form at least throughout the small intestine, minimizing the risk of intestinal mucosal damage from free iron and potentially reducing local toxicity.
-
SynonymsIron(III) 2-methyl-4-oxo-4H-pyran-3-olate
-
PathwayOthers
-
TargetOther Targets
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number33725-54-1
-
Formula Weight431.154
-
Molecular FormulaC18H15FeO9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (28.99 mM)
-
SMILESCC1=C2[O-][Fe+3]34([O-]C5=C(C)OC=CC5=[O]3)([O-]C3=C(C)OC=CC3=[O]4)[O]=C2C=CO1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peixoto JF, Ramos YJ, de Lima Moreira D, Alves CR, Gon?alves-Oliveira LF. Potential of Piper spp. as a source of new compounds for the leishmaniases treatment. Parasitol Res. 2021 Aug;120(8):2731-2747.
molnova catalog
related products
-
ent-Amyloid b-Protei...
ent-Amyloid b-Protein (1-42)
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
-
Siamenoside I
Siamenoside I is a natural product,and is one of the mogrosides that has several kinds of bioactivities, it exhibits maltase inhibitory effect with the IC50 value of 12 mM.
